Hidradenitis suppurativa in sexual and gender minorities: A review and considerations for providers.

HIV/AIDS LGBTQIA health gender identity hidradenitis suppurativa inflammation/inflammatory medical dermatology sexual and gender minorities sexuality squamous cell carcinoma

Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
10 2023
Historique:
received: 12 10 2021
revised: 26 01 2022
accepted: 01 03 2022
medline: 20 9 2023
pubmed: 15 3 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

The literature on hidradenitis suppurativa in sexual and gender minorities remains sparse. This review article aims to discuss critical factors for providers to consider in lesbian, gay, bisexual, transgender, queer, intersex, and asexual patients with hidradenitis suppurativa, including associated comorbidities, gender-affirming hormonal therapy, squamous cell carcinoma, infections in HIV-positive patients, and creating a welcoming clinic for sexual and gender minority patients.

Identifiants

pubmed: 35283243
pii: S0190-9622(22)00385-1
doi: 10.1016/j.jaad.2022.03.008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

795-801

Informations de copyright

Copyright © 2022 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest Maria Aleshin - received research funding from UCB, consultant for Abbvie.

Auteurs

Jason Gomez (J)

Stanford School of Medicine, Stanford, California; Stanford Graduate School of Business, Stanford, California.

Leandra A Barnes (LA)

Department of Dermatology, Stanford University School of Medicine, Stanford, California.

John Montgomery Yost (JM)

Department of Dermatology, Stanford University School of Medicine, Stanford, California; Crossover Health, Menlo Park, California.

Justin Gordon (J)

Department of Dermatology, Stanford University School of Medicine, Stanford, California.

Brian A Ginsberg (BA)

Chelsea Skin and Laser, New York, New York.

Maria Aleshin (M)

Department of Dermatology, Stanford University School of Medicine, Stanford, California. Electronic address: maleshin@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH